We then measured anti‐IFN‐α2 Abs levels in the sera from the critically ill COVID‐19 patients: 21 of 84 (25%) were positive and had values above the cut‐off (> 34 ng mL−1). This evidence concerns the gene IFNA2 and COVID-19.